Logo image of MAGN

MAGNERA CORP (MAGN) Stock Fundamental Analysis

USA - NYSE:MAGN - US55939A1079 - Common Stock

9.09 USD
+0.53 (+6.19%)
Last: 10/31/2025, 8:04:01 PM
9.09 USD
0 (0%)
After Hours: 10/31/2025, 8:04:01 PM
Fundamental Rating

3

Overall MAGN gets a fundamental rating of 3 out of 10. We evaluated MAGN against 9 industry peers in the Paper & Forest Products industry. MAGN has a bad profitability rating. Also its financial health evaluation is rather negative. MAGN is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year MAGN has reported negative net income.
MAGN had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: MAGN reported negative net income in multiple years.
In multiple years MAGN reported negative operating cash flow during the last 5 years.
MAGN Yearly Net Income VS EBIT VS OCF VS FCFMAGN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M 300M

1.2 Ratios

MAGN has a Return On Assets (-3.26%) which is in line with its industry peers.
With a Return On Equity value of -11.87%, MAGN is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
The Return On Invested Capital of MAGN (1.50%) is better than 66.67% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MAGN is below the industry average of 5.72%.
The last Return On Invested Capital (1.50%) for MAGN is above the 3 year average (1.29%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -3.26%
ROE -11.87%
ROIC 1.5%
ROA(3y)-5.49%
ROA(5y)-3.3%
ROE(3y)-30.19%
ROE(5y)-18.15%
ROIC(3y)1.29%
ROIC(5y)2.28%
MAGN Yearly ROA, ROE, ROICMAGN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20 -40 -60

1.3 Margins

MAGN has a Operating Margin of 2.48%. This is in the better half of the industry: MAGN outperforms 66.67% of its industry peers.
In the last couple of years the Operating Margin of MAGN has declined.
The Gross Margin of MAGN (10.55%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of MAGN has declined.
Industry RankSector Rank
OM 2.48%
PM (TTM) N/A
GM 10.55%
OM growth 3Y-34.91%
OM growth 5Y-7.66%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.6%
GM growth 5Y-9.06%
MAGN Yearly Profit, Operating, Gross MarginsMAGN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 -20

More info and screens

3

2. Health

2.1 Basic Checks

MAGN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, MAGN has less shares outstanding
Compared to 5 years ago, MAGN has less shares outstanding
Compared to 1 year ago, MAGN has a worse debt to assets ratio.
MAGN Yearly Shares OutstandingMAGN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
MAGN Yearly Total Debt VS Total AssetsMAGN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

Based on the Altman-Z score of 1.00, we must say that MAGN is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of MAGN (1.00) is worse than 88.89% of its industry peers.
A Debt/Equity ratio of 1.76 is on the high side and indicates that MAGN has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.76, MAGN is doing worse than 66.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.76
Debt/FCF N/A
Altman-Z 1
ROIC/WACC0.21
WACC7.23%
MAGN Yearly LT Debt VS Equity VS FCFMAGN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 2.54 indicates that MAGN has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.54, MAGN is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
MAGN has a Quick Ratio of 1.63. This is a normal value and indicates that MAGN is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of MAGN (1.63) is better than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 2.54
Quick Ratio 1.63
MAGN Yearly Current Assets VS Current LiabilitesMAGN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

More info and screens

5

3. Growth

3.1 Past

MAGN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -93.18%.
The Revenue has decreased by -7.09% in the past year.
The Revenue has been growing by 9.85% on average over the past years. This is quite good.
EPS 1Y (TTM)-93.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-7.09%
Revenue growth 3Y14.77%
Revenue growth 5Y9.85%
Sales Q2Q%152.63%

3.2 Future

MAGN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 36.60% yearly.
Based on estimates for the next years, MAGN will show a very strong growth in Revenue. The Revenue will grow by 21.34% on average per year.
EPS Next Y-14%
EPS Next 2Y16.28%
EPS Next 3Y41.51%
EPS Next 5Y36.6%
Revenue Next Year120.68%
Revenue Next 2Y41.92%
Revenue Next 3Y28.37%
Revenue Next 5Y21.34%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MAGN Yearly Revenue VS EstimatesMAGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
MAGN Yearly EPS VS EstimatesMAGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 5 10 15 20

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MAGN. In the last year negative earnings were reported.
Also next year MAGN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MAGN Price Earnings VS Forward Price EarningsMAGN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as MAGN.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.94
MAGN Per share dataMAGN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

A more expensive valuation may be justified as MAGN's earnings are expected to grow with 41.51% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.28%
EPS Next 3Y41.51%

More info and screens

0

5. Dividend

5.1 Amount

MAGN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MAGNERA CORP

NYSE:MAGN (10/31/2025, 8:04:01 PM)

After market: 9.09 0 (0%)

9.09

+0.53 (+6.19%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryPaper & Forest Products
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)01-07 2026-01-07
Inst Owners101.93%
Inst Owner Change0.83%
Ins Owners0.54%
Ins Owner Change19.9%
Market Cap323.60M
Revenue(TTM)1.39B
Net Income(TTM)-134247000
Analysts45.71
Price Target13.26 (45.87%)
Short Float %11.83%
Short Ratio5.58
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.23%
Min Revenue beat(2)-4.4%
Max Revenue beat(2)-4.06%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-7.14%
PT rev (3m)-13.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.12
P/FCF N/A
P/OCF N/A
P/B 0.29
P/tB 1.67
EV/EBITDA 7.94
EPS(TTM)-0.85
EYN/A
EPS(NY)-0.55
Fwd EYN/A
FCF(TTM)-2.39
FCFYN/A
OCF(TTM)-0.85
OCFYN/A
SpS75.76
BVpS31.77
TBVpS5.45
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -3.26%
ROE -11.87%
ROCE 1.9%
ROIC 1.5%
ROICexc 1.63%
ROICexgc 2.29%
OM 2.48%
PM (TTM) N/A
GM 10.55%
FCFM N/A
ROA(3y)-5.49%
ROA(5y)-3.3%
ROE(3y)-30.19%
ROE(5y)-18.15%
ROIC(3y)1.29%
ROIC(5y)2.28%
ROICexc(3y)1.4%
ROICexc(5y)2.53%
ROICexgc(3y)1.77%
ROICexgc(5y)3.33%
ROCE(3y)1.65%
ROCE(5y)2.9%
ROICexgc growth 3Y-33.98%
ROICexgc growth 5Y-5.57%
ROICexc growth 3Y-31.54%
ROICexc growth 5Y-3.54%
OM growth 3Y-34.91%
OM growth 5Y-7.66%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.6%
GM growth 5Y-9.06%
F-Score4
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 1.76
Debt/FCF N/A
Debt/EBITDA 7.73
Cap/Depr 28.75%
Cap/Sales 2.03%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.54
Quick Ratio 1.63
Altman-Z 1
F-Score4
WACC7.23%
ROIC/WACC0.21
Cap/Depr(3y)52.93%
Cap/Depr(5y)52.63%
Cap/Sales(3y)2.58%
Cap/Sales(5y)2.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-93.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-14%
EPS Next 2Y16.28%
EPS Next 3Y41.51%
EPS Next 5Y36.6%
Revenue 1Y (TTM)-7.09%
Revenue growth 3Y14.77%
Revenue growth 5Y9.85%
Sales Q2Q%152.63%
Revenue Next Year120.68%
Revenue Next 2Y41.92%
Revenue Next 3Y28.37%
Revenue Next 5Y21.34%
EBIT growth 1Y117.08%
EBIT growth 3Y-25.3%
EBIT growth 5Y1.43%
EBIT Next Year515.25%
EBIT Next 3Y84.42%
EBIT Next 5Y60.13%
FCF growth 1Y-62.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-177.22%
OCF growth 3YN/A
OCF growth 5YN/A

MAGNERA CORP / MAGN FAQ

What is the fundamental rating for MAGN stock?

ChartMill assigns a fundamental rating of 3 / 10 to MAGN.


What is the valuation status of MAGNERA CORP (MAGN) stock?

ChartMill assigns a valuation rating of 1 / 10 to MAGNERA CORP (MAGN). This can be considered as Overvalued.


How profitable is MAGNERA CORP (MAGN) stock?

MAGNERA CORP (MAGN) has a profitability rating of 3 / 10.


What is the earnings growth outlook for MAGNERA CORP?

The Earnings per Share (EPS) of MAGNERA CORP (MAGN) is expected to decline by -14% in the next year.


How sustainable is the dividend of MAGNERA CORP (MAGN) stock?

The dividend rating of MAGNERA CORP (MAGN) is 0 / 10 and the dividend payout ratio is 0%.